MK615, a Prunus mume Steb. et Zucc ('Ume') extract, attenuates the growth of A375 melanoma cells by inhibiting the ERK1/2-Id-1 pathway

Phytotherapy Research

Volumn 26, Issue 6, 2012, Pages 833-838

  Tada, Ko Ichi ^a   Kawahara, Ko Ichi ^a,b   Matsushita, Shigeto ^a   Hashiguchi, Teruto ^a   Maruyama, Ikuro ^a   Kanekura, Takuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b OSAKA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

ERK1 2; inhibitor of DNA binding 1 (Id 1); melanoma; MK615

Indexed keywords

INDOMETACIN; INHIBITOR OF DIFFERENTIATION 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL 2; PROTEIN KINASE B; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME INHIBITION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; MICROARRAY ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL DEATH; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MAP KINASE SIGNALING SYSTEM; MELANOMA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-BCL-2; PRUNUS; RNA INTERFERENCE; RNA, MESSENGER;

PRUNUS MUME;

EID: 84861829646     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3645     Document Type: Article

References (20)

1. Adachi M, Suzuki Y, Mizuta T, et al,. 2007. The 'Prunus mume Sieb. et Zucc' (Ume) is a rich natural source of novel anti-cancer substance. Int J Food Prop 10: 375-384.
2. Al-Jahdari WS, Sakurai H, Yoshida Y, Mobaraki A, Suzuki Y, Nakano T,. 2011. MK615, a prospective anti-proliferative agent, enhances CD4/CD8 ratio after exposure to irradiation. Int J Radiat Biol 87: 81-90.
3. Bhattacharya U, Halder B, Mukhopadhyay S, Giri AK,. 2009. Role of oxidation-triggered activation of JNK and p38 MAPK in black tea polyphenols induced apoptotic death of A375 cells. Cancer Sci 100: 1971-1978.
4. Kawahara K, Hashiguchi T, Masuda K, et al., 2009. Mechanism of HMGB1 release inhibition from RAW264.7 cells by oleanolic acid in Prunus mume Sieb. et Zucc. Int J Mol Med 23: 615-620.
5. Kim H, Chung H, Kim HJ, et al., 2008. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells. Breast Cancer Res Treat 11: 2287-2296.
6. Kobori M, Iwashita K, Shinmoto H, Tsushida T,. 1999. Phloretin-induced apoptosis in B16 melanoma 4A5 cells and HL60 human leukemia cells. Biosci Biotechnol Biochem 63: 719-725.
7. Matsushita S, Tada K, Kawahara K, et al., 2010. Advanced malignant melanoma responding to Prunus mume Sieb. Et Zucc (Ume) extract-Case report and in vitro study. Exp Ther Med 1: 569-574.
8. Meng X, Kawahara K, Matsushita K, et al., 2009. Attenuation of LPS-induced iNOS expression by 1,5-anhydro-d-fructose. Biochem Biophys Res Commun 38: 742-746.
9. Mori S, Sawada T, Okada T, Ohsawa T, Adachi M, Keiichi K,. 2007. New anti-proliferative agent, MK615, from Japanese apricot 'Prunus mume' induces striking autophagy in colon cancer cells in vitro. World J Gastroenterol 13: 6512-6517.
10. Morimoto Y, Kawahara K, Tancharoen S, et al,. 2008. Tumor necrosis factor-alpha stimulates gingival epithelial cells to release high mobility-group box 1. J Periodont Res 43: 76-83.
11. Nakagawa A, Sawada T, Okada T, Ohsawa T, Adachi M, Kubota K,. 2007. New antineoplastic agent, MK615, from UME (a variety of) Japanese apricot inhibits growth of breast cancer cells in vitro. Breast J 13: 44-49.
12. Okada T, Sawada T, Osawa T, Adachi M, Kubota K,. 2007. A novel anti-cancer substance, MK615, from Ume, a variety of Japanese apricot, inhibits growth of hepatocellular carcinoma cells by suppressing Aurora A kinase activity. Hepatogastroenterology 54: 1770-1774.
13. Okada T, Sawada T, Osawa T, Adachi M, Kubota K,. 2008. MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases. World J Gastroenterol 14: 1378-1382.
14. Polsky D, Young AZ, Busam KJ, Alani RM,. 2001. The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas. Cancer Res 61: 6008-6011.
15. Redondo P, Bandrés E, Solano T, Okroujnov I, Garcia-Foncillas J,. 2000. Vascular endothelial growth factor (VEGF) and melanoma. N-acetylcysteine downregulates VEGF production in vitro. Cytokine 12: 374-378.
16. Ryu B, Kim DS, DeLuca AM, et al,. 2007. Id1 expression is transcriptionally regulated in radial growth phase melanomas. Int J Cancer 1211: 1705-1709.
17. Straume O, Akslen LA,. 2005. Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma. Br J Cancer 93: 933-938.
18. Sumimoto S, Imabayashi F, Iwata T, Kawakami Y,. 2006. The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells. J Exp Med 203: 1651-1656.
19. Sun Q, Cong R, Yan H, et al,. 2009. Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. Oncol Rep 22: 563-567.
20. Tas F, Oguz H, Argon A, et al,. 2005. The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: Serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma. Med Oncol 22: 241-246.